Kinaxis Inc. (TSE:KXS – Get Rating) Senior Officer Anne Gillian Robinson sold 15,000 shares of Kinaxis stock in a transaction on Friday, May 19th. The stock was sold at an average price of C$184.00, for a total value of C$2,760,000.00.
Kinaxis Price Performance
Shares of Kinaxis stock opened at C$180.99 on Wednesday. The stock’s 50-day simple moving average is C$181.69 and its 200-day simple moving average is C$163.60. Kinaxis Inc. has a 52 week low of C$119.48 and a 52 week high of C$190.31. The company has a market capitalization of C$5.12 billion, a price-to-earnings ratio of 441.44, a PEG ratio of 3.60 and a beta of 0.80. The company has a quick ratio of 2.29, a current ratio of 2.43 and a debt-to-equity ratio of 12.86.
Kinaxis (TSE:KXS – Get Rating) last announced its quarterly earnings data on Wednesday, March 1st. The company reported C$0.83 EPS for the quarter, beating the consensus estimate of C$0.34 by C$0.49. Kinaxis had a return on equity of 2.25% and a net margin of 2.36%. The business had revenue of C$133.71 million for the quarter, compared to the consensus estimate of C$134.05 million. As a group, analysts expect that Kinaxis Inc. will post 1.733897 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Japan, Hong Kong, The Netherlands, South Korea, the United Kingdom, Singapore, France, Ireland, Germany, India, and Canada. It offers Kinaxis, a cloud-based software-as-a-service platform, which provides advanced planning, sales and operations planning, supply and demand planning, inventory management, and command and control center services.
Featured Stories
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.